Skip to main content

Advertisement

SpringerLink
Log in

Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva

  • Short Communication
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

Both dermal and ocular melanocytic nevi have been reported to undergo changes during pregnancy. This has been proposed to be related to hormonal influences; however, few studies have provided any proof. We therefore set out to evaluate the expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva.

Methods

Formalin-fixed, paraffin-embedded material from 76 tumors - 69 conjunctival nevi, 5 specimens of primary acquired melanosis (PAM), and 2 conjunctival melanomas - were included in a tissue microarray (TMA) format. The TMA sections were analyzed by immunohistochemistry with antibodies for progesterone and estrogen receptors, and cell cycle-related proteins (p16, MIB1-Ki67).

Results

Progesterone receptors were highly (96%) and similarly expressed in all lesions. In addition, progesterone receptor expression showed a tendency to increase with age (p=0.06). In contrast, estrogen receptor expression was completely absent in all tumors. The cell cycle regulator p16 was expressed in 97% of the lesions. The proliferation marker MIB1-Ki67 was expressed at low levels (mean±SD: 13±14%) in 79% of the lesions. No differences of expression were found between the different lesions and nevi types. The mean age of the patients was highest in conjunctival melanoma (70±22 years), followed by PAM (60±19 years) and nevi (36±18 SD years). The different types of nevi also showed significant age dependency (junctional 25±17 years, compound 34±17 years, dermal 49±15 years).

Conclusion

Our findings reveal the expression of progesterone, but not estrogen, in melanocytic lesions of the ocular conjunctiva. In benign conjunctival lesions, p16 and MIB1-Ki67 expression was comparable to that in benign nevi of the skin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Auw-Haedrich C, Feltgen N (2003) Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters. Graefe Arch Clin Exp Ophthalmol 241:705–709

    Article  CAS  Google Scholar 

  2. Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, Chen Y, Mahlamaki E, Schraml P, Moch H, Willi N, Elkahloun AG, Pretlow TG, Gasser TC, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 91:1758–1764

    Article  PubMed  CAS  Google Scholar 

  3. Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch MJ, Sauter G, Kallioniemi OP (1999) Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59:803–806

    PubMed  CAS  Google Scholar 

  4. Chowers I, Livni N, Frucht-Pery J, Pe'er J (1999) Immunostaining of the estrogen receptor in conjunctival primary acquired melanosis. Ophthalmic Res 31:210–212

    Article  PubMed  CAS  Google Scholar 

  5. Ellis DL, Wheeland RG, Solomon H (1985) Estrogen and progesterone receptors in melanocytic lesions. Occurrence in patients with dysplastic nevus syndrome. Arch Dermatol 121:1282–1285

    Article  PubMed  CAS  Google Scholar 

  6. Ellis DL, Wheeland RG, Solomon H (1985) Estrogen and progesterone receptors in congenital melanocytic nevi. J Am Acad Dermatol 12:235–244

    PubMed  CAS  Google Scholar 

  7. Ellis DL, Wheeland RG (1986) Increased nevus estrogen and progesterone ligand binding related to oral contraceptives or pregnancy. J Am Acad Dermatol 14:25–31

    Article  PubMed  CAS  Google Scholar 

  8. Esmaeli B, Harvey JT, Hewlett B (2000) Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology 107:180–184

    Article  PubMed  CAS  Google Scholar 

  9. Foss AJ, Alexander RA, Guille MJ, Hungerford JL, McCartney AC, Lightman S (1995) Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology 102:431–435

    PubMed  CAS  Google Scholar 

  10. Fuchsjager-Mayrl G, Nepp J, Schneeberger C, Sator M, Dietrich W, Wedrich A, Huber J, Tschugguel W (2002) Identification of estrogen and progesterone receptor mRNA expression in the conjunctiva of premenopausal women. Investig Ophthalmol Vis Sci 43:2841–2844

    Google Scholar 

  11. Gans LA, Lee SF, Lemp MA, Pepose JS (1990) Estrogen and progesterone receptors and human conjunctiva. Am J Ophthalmol 109:474–477

    PubMed  CAS  Google Scholar 

  12. Gerner N, Norregaard JC, Jensen OA, Prause JU (1996) Conjunctival naevi in Denmark 1960–1980. A 21-year follow-up study. Acta Ophthalmol Scand 74:334–337

    PubMed  CAS  Google Scholar 

  13. Jemec GB, Bhogal BS, Wojnarowska F (1987) Are acquired nevi oestrogen-dependent tumours? Acta Derm Venereol 67:451–453

    PubMed  CAS  Google Scholar 

  14. Katz VL, Farmer RM, Dotters D (2002) Focus on primary care: from nevus to neoplasm: myths of melanoma in pregnancy. Obstet Gynecol Surv 57:112–119

    Article  PubMed  Google Scholar 

  15. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    Article  PubMed  CAS  Google Scholar 

  16. Lecavalier MA, From L, Gaid N (1990) Absence of estrogen receptors in dysplastic nevi and malignant melanoma. J Am Acad Dermatol 23:242–246

    PubMed  CAS  Google Scholar 

  17. Lee HJ, Ha SJ, Lee SJ, Kim JW (2000) Melanocytic nevus with pregnancy-related changes in size accompanied by apoptosis of nevus cells: a case report. J Am Acad Dermatol 42:936–938

    Article  PubMed  CAS  Google Scholar 

  18. Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Luc Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194:349–357

    Article  PubMed  CAS  Google Scholar 

  19. Paridaens DA, Alexander RA, Hungerford JL, McCartney AC (1991) Oestrogen receptors in conjunctival malignant melanoma: immunocytochemical study using formalin fixed paraffin wax sections. J Clin Pathol 44:840–843

    Article  PubMed  CAS  Google Scholar 

  20. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G (1999) Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5:1966–1975

    PubMed  CAS  Google Scholar 

  21. Simon R, Nocito A, Hubscher T, Bucher C, Torhorst J, Schraml P, Bubendorf L, Mihatsch MM, Moch H, Wilber K, Schotzau A, Kononen J, Sauter G (2001) Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst 93:1141–1146

    Article  PubMed  CAS  Google Scholar 

  22. Spelsberg H, Klueppel M, Reinhard T, Glaeser M, Niederacher D, Beckmann MW, Sundmacher R (2004) Detection of oestrogen receptors (ER) alpha and beta in conjunctiva, lacrimal gland, and tarsal plates. Eye 18:729–733

    Article  PubMed  CAS  Google Scholar 

  23. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249–2256

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Eye Clinic Freiburg, Killianstrasse 5, 79106, Freiburg, Germany

    Mona Pache

  2. Institute of Pathology, University Hospital, 4003, Basel, Switzerland

    Katharina Glatz-Krieger & Guido Sauter

  3. Department of Ophthalmopathology, University Eye Clinic, 4012, Basel, Switzerland

    Peter Meyer

Authors
  1. Mona Pache
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katharina Glatz-Krieger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guido Sauter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mona Pache.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pache, M., Glatz-Krieger, K., Sauter, G. et al. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva. Graefe's Arch Clin Exp Ophthalmo 244, 113–117 (2006). https://doi.org/10.1007/s00417-005-0035-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-005-0035-2

Keywords

Search

Navigation